Altered expression of NFY-C and RORA in colorectal adenocarcinomas

Acta Histochemica

Volumn 114, Issue 6, 2012, Pages 553-561

  Kottorou, Anastasia E ^a   Antonacopoulou, Anna G ^a   Dimitrakopoulos, Fotinos Ioannis D ^a   Tsamandas, Athanasios C ^b   Scopa, Chrisoula D ^b   Petsas, Theodore ^a   Kalofonos, Haralabos P ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Clinicopathological characteristics; Colorectal adenocarcinoma; Disease progression; Immunohistochemistry; MRNA; Primary site

Indexed keywords

FLUOROURACIL; FOLINIC ACID; MESSENGER RNA; NUCLEAR FACTOR Y; NUCLEAR FACTOR Y SUBUNIT C; RETINOID RELATED ORPHAN RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CARCINOGENESIS; COLON MUCOSA; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NUCLEOTIDE SEQUENCE; POSTOPERATIVE CARE; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RECTUM CANCER;

ADENOCARCINOMA; AGED; CCAAT-BINDING FACTOR; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EUKARYOTA;

EID: 84861676524     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2011.10.005     Document Type: Article

References (46)

1. Alabert C., Rogers L., Kahn L., Niellez S., Fafet P., Cerulis S., et al. Cell type-dependent control of NF-Y activity by TGF-beta. Oncogene 2006, 25:3387-3396.
2. Antonacopoulou A.G., Grivas P.D., Skarlas L., Kalofonos M., Scopa C.D., Kalofonos H.P. POLR2F ATP6V0A1 PRNP expression in colorectal cancer: new molecules with prognostic significance?. Anticancer Res 2008, 28:1221-1227.
3. Assimakopoulos S.F., Tsamandas A.C., Georgiou C.D., Vagianos C.E., Scopa C.D. Bombesin and neurotensin exert antiproliferative effects on oval cells and augment the regenerative response of the cholestatic rat liver. Peptides 2010, 31:2294-2303.
4. Bellorini M., Zemzoumi K., Farina A., Berthelsen J., Piaggio G., Mantovani R. Cloning and expression of human NF-YC. Gene 1997, 193:119-125.
5. Boily G., Ouellet S., Langlois S., Lariviere M., Drouin R., Sinnett D. In vivo footprinting analysis of the Glypican 3 (GPC3) promoter region in neuroblastoma cells. Biochim Biophys Acta 2007, 1769:182-193.
6. Borghini S., Vargiolu M., Di Duca M., Ravazzolo R., Ceccherini I. Nuclear factor Y drives basal transcription of the human TLX3, a gene overexpressed in T-cell acute lymphocytic leukemia. Mol Cancer Res 2006, 4:635-643.
7. Boukhtouche F., Mariani J., Tedgui A. The " CholesteROR" protective pathway in the vascular system. Arterioscler Thromb Vasc Biol 2004, 24:637-643.
8. Buttel I., Fechter A., Schwab M. Common fragile sites and cancer: targeted cloning by insertional mutagenesis. Ann N Y Acad Sci 2004, 1028:14-27.
9. Ceribelli M., Benatti P., Imbriano C., Mantovani R. NF-YC complexity is generated by dual promoters and alternative splicing. J Biol Chem 2009, 284:34189-34200.
10. Dooley T.P. Molecular biology of the human phenol sulfotransferase gene family. J Exp Zool 1998, 282:223-230.
11. Frontini M., Imbriano C., Manni I., Mantovani R. Cell cycle regulation of NF-YC nuclear localization. Cell Cycle 2004, 3:217-222.
12. Giguere V., Tini M., Flock G., Ong E., Evans R.M., Otulakowski G. Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev 1994, 8:538-553.
13. Green D.R., Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009, 458:1127-1130.
14. Grivas P.D., Antonacopoulou A., Tzelepi V., Sotiropoulou-Bonikou G., Kefalopoulou Z., Papavassiliou A.G., et al. HER-3 in colorectal tumourigenesis: from mRNA levels through protein status to clinicopathologic relationships. Eur J Cancer 2007, 43:2602-2611.
15. Gu F., Hsu H.K., Hsu P.Y., Wu J., Ma Y., Parvin J., et al. Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data. BMC Syst Biol 2010, 4:170.
16. Hamilton B.A., Frankel W.N., Kerrebrock A.W., Hawkins T.L., FitzHugh W., Kusumi K., et al. Disruption of the nuclear hormone receptor RORalpha in staggerer mice. Nature 1996, 379:736-739.
17. Hatanaka Y., Hashizume K., Kamihara Y., Itoh H., Tsuda H., Osamura R.Y., et al. Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTestTM in breast carcinoma by image analysis. Pathol Int 2001, 51:33-36.
18. Jetten A.M. Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs). Curr Drug Targets Inflamm Allergy 2004, 3:395-412.
19. Kahle J., Baake M., Doenecke D., Albig W. Subunits of the heterotrimeric transcription factor NF-Y are imported into the nucleus by distinct pathways involving importin beta and importin 13. Mol Cell Biol 2005, 25:5339-5354.
20. Komuro K., Tada M., Tamoto E., Kawakami A., Matsunaga A., Teramoto K., et al. Right- and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis. J Surg Res 2005, 124:216-224.
21. Lee M.G., Pedersen P.L. Glucose metabolism in cancer: importance of transcription factor-DNA interactions within a short segment of the proximal region of the type II hexokinase promoter. J Biol Chem 2003, 278:41047-41058.
22. Lu Y., Yi Y., Liu P., Wen W., James M., Wang D., et al. Common human cancer genes discovered by integrated gene-expression analysis. PLoS One 2007, 2:e1149.
23. Mach B., Steimle V., Martinez-Soria E., Reith W. Regulation of MHC class II genes: lessons from a disease. Annu Rev Immunol 1996, 14:301-331.
24. Mantovani R. A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res 1998, 26:1135-1143.
25. Mantovani R., Superti-Furga G., Gilman J., Ottolenghi S. The deletion of the distal CCAAT box region of the A gamma-globin gene in black HPFH abolishes the binding of the erythroid specific protein NFE3 and of the CCAAT displacement protein. Nucleic Acids Res 1989, 17:6681-6691.
26. Marziali G., Perrotti E., Ilari R., Testa U., Coccia E.M., Battistini A. Transcriptional regulation of the ferritin heavy-chain gene: the activity of the CCAAT binding factor NF-Y is modulated in heme-treated Friend leukemia cells and during monocyte-to-macrophage differentiation. Mol Cell Biol 1997, 17:1387-1395.
27. Missbach M., Jagher B., Sigg I., Nayeri S., Carlberg C., Wiesenberg I. Thiazolidine diones, specific ligands of the nuclear receptor retinoid Z receptor/retinoid acid receptor-related orphan receptor alpha with potent antiarthritic activity. J Biol Chem 1996, 271:13515-13522.
28. Moretti R.M., Marelli M.M., Motta M., Limonta P. Role of the orphan nuclear receptor ROR alpha in the control of the metastatic behavior of androgen-independent prostate cancer cells. Oncol Rep 2002, 9:1139-1143.
29. Moretti R.M., Marelli M.M., Motta M., Polizzi D., Monestiroli S., Pratesi G., et al. Activation of the orphan nuclear receptor RORalpha induces growth arrest in androgen-independent DU 145 prostate cancer cells. Prostate 2001, 46:327-335.
30. Niida A., Smith A.D., Imoto S., Tsutsumi S., Aburatani H., Zhang M.Q., et al. Integrative bioinformatics analysis of transcriptional regulatory programs in breast cancer cells. BMC Bioinformatics 2008, 9:404.
31. Ohno Y., Hattori A., Ueda M., Kageyama S., Yoshiki T., Kakeya H. Multiple NF-Y-binding CCAAT boxes are essential for transcriptional regulation of the human C7orf24 gene, a novel tumor-associated gene. FEBS J 2011, 278:4088-4099.
32. Panno M.L., Giordano F., Palma M.G., Bartella V., Rago V., Maggiolini M., et al. Evidence that bergapten, independently of its photoactivation, enhances p53 gene expression and induces apoptosis in human breast cancer cells. Curr Cancer Drug Targets 2009, 9:469-481.
33. Park S.H., Yu G.R., Kim W.H., Moon W.S., Kim J.H., Kim D.G. NF-Y-dependent cyclin B2 expression in colorectal adenocarcinoma. Clin Cancer Res 2007, 13:858-867.
34. Pawitan Y., Michiels S., Koscielny S., Gusnanto A., Ploner A. False discovery rate, sensitivity and sample size for microarray studies. Bioinformatics 2005, 21:3017-3024.
35. Peng Y., Jahroudi N. The NFY transcription factor functions as a repressor and activator of the von Willebrand factor promoter. Blood 2002, 99:2408-2417.
36. Ramakers C., Ruijter J.M., Deprez R.H., Moorman A.F. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 2003, 339:62-66.
37. Ronchi A., Berry M., Raguz S., Imam A., Yannoutsos N., Ottolenghi S., et al. Role of the duplicated CCAAT box region in gamma-globin gene regulation and hereditary persistence of fetal haemoglobin. EMBO J 1996, 15:143-149.
38. Roy B., Lee A.S. Transduction of calcium stress through interaction of the human transcription factor CBF with the proximal CCAAT regulatory element of the grp78/BiP promoter. Mol Cell Biol 1995, 15:2263-2274.
39. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386.
40. Sato T.K., Panda S., Miraglia L.J., Reyes T.M., Rudic R.D., McNamara P., et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 2004, 43:527-537.
41. Smith D.I., Zhu Y., McAvoy S., Kuhn R. Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett 2006, 232:48-57.
42. Thomassen M., Tan Q., Kruse T.A. Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer. BMC Cancer 2008, 8:394.
43. Tsamandas A.C., Thomopoulos K., Zolota V., Kourelis T., Karatzas T., Ravazoula P., et al. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study. Mod Pathol 2003, 16:1273-1288.
44. Vis A.N., Kranse R., Nigg A.L., van der Kwast T.H. Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections. Am J Clin Pathol 2000, 113:369-373.
45. Wolpin B.M., Mayer R.J. Systemic treatment of colorectal cancer. Gastroenterology 2008, 134:1296-1310.
46. Zhu Y., McAvoy S., Kuhn R., Smith D.I. R.O.R.A. a large common fragile site gene, is involved in cellular stress response. Oncogene 2006, 25:2901-2908.